The Department of Defense (DOD) is seeking proposals for a Small Business Innovation Research (SBIR) program with a focus on developing a high-throughput pathogen inactivation device using psoralen-UV-A irradiation. The device should be capable of inactivating pathogens at various volumes (ranging from 0.01 L to 50 L) and facilitate the rapid development of vaccines against emerging infectious threats. The device will play a crucial role in protecting civilian and military personnel from infectious diseases and reducing lost duty days. The project will be conducted in two phases, with Phase I focusing on feasibility and Phase II on developing a fully functional prototype. The ultimate goal is to partner with vaccine manufacturers to commercialize the device for the production of psoralen-inactivated vaccines against a wide range of diseases caused by viruses. The device can also have applications in biopharmaceutical production and research laboratories for inactivating high-containment pathogens. The project has a funding opportunity for small businesses and offers a significant opportunity to advance the field of agile vaccine platforms and combat emerging infectious threats.